Recently, PCBP1 has been shown as a negative regulator of thyroid carcinoma [44], a negative regulator of EMT related to metastasis in NSCLC [45], while PCBP1 expression is suppressed in peritoneal gastric cancer metastasis [46]. Here, PCBP1 is linked to thyroid gland carcinoma.